Skip to main content
dose.wiki is still in beta. Entries may contain inaccuracies and/or lack citations. See our docs for more info.
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Ethylone

Ethylone molecule structureEthylone molecule structure
3,4-methylenedioxy-N-ethylcathinone
bk-MDEA, MDEC, 3,4-MDEC
Psychoactive Class
Chemical Class

Ethylone is a synthetic entactogen and stimulant of the cathinone class.citation needed It is the β-keto analog of MDEA and emerged commercially around 2011 with minimal prior documentation of human use. Ethylone is commonly sold as a substitute or counterfeit for MDMA and methylone due to methylone's declining market availability. It is reported to be less potent than methylone, with effects that lean more toward classical stimulation than entactogenic warmth.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~75 mg
Light75-150 mg
Moderate150-225 mg
Strong225-325 mg
Heavy325+ mg

Duration

Onset15-45 minutes
Peak1-1.5 hours
Offset1-2 hours
After Effects2-12 hours
Total2-4 hours

Subjective Effects

Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.

The experience is that of a mild entactogen, broadly comparable to MDMA in character but consistently reported as subtler and less satisfying. Users frequently describe the effects as underwhelming relative to expectations, with the emotional warmth and euphoria of related empathogens present in a muted form. It is also reported to be less potent than its close relative methylone.

Physical

A mild stimulating effect accompanies the experience, consistent with its cathinone stimulant profile.

Cognitive

The headspace is a gentle, empathogenic one, with mild mood elevation and social warmth that fall noticeably short of the intensity associated with MDMA.

Emotional

Empathogenic effects are present but notably weaker than those of MDMA, often leaving users underwhelmed.

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Marquis(MQ)
white → yellow2
Mecke(ME)
white → yellow2
Mandelin(MD)
yellow2 → brown2
Liebermann(LB)
white → yellow2
Powered by PROtestkit.eu

Pharmacology

Pharmacodynamics

Ethylone functions as a mixed monoamine reuptake inhibitor and releasing agent, acting on the serotonin, norepinephrine, and dopamine transporters.citation needed Relative to methylone, it displays approximately three-fold lower affinity for the serotonin transporter while maintaining similar affinity for the norepinephrine and dopamine transporters, resulting in a more balanced catecholaminergic-to-serotonergic activity profile. Although ethylone retains robust releasing capabilities, its overall pharmacological character has been described as more consistent with reuptake inhibition than with monoamine release.

Pharmacokinetics

Based on analysis of human and rat urine, ethylone undergoes metabolism via two primary pathways: N-deethylation to the corresponding primary amine and reduction of the beta-keto group to the respective alcohol.citation needed

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

5-HTPAlcoholCocaineDXMDissociativesMAOIsMDMAMXENBOMe compoundsSNRIsSSRIsSerotonin releasersStimulantsTramadol
Powered by TripSit

Tolerance

Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.

Full Tolerance
Repeated ethylone use over time can produce tolerance to many effects, causing users to need larger doses for comparable results.
Baseline Reset
1-2 weeks
Half Tolerance
3-7 days
Cross Tolerance

Dopaminergic stimulants

Harm Potential

Addiction & Dependence

Psychological

Moderate

Chronic use is regarded as moderately addictive, carries a high abuse potential, and can produce psychological dependence. If addiction develops, stopping suddenly may cause cravings.

Physical

Low

Withdrawal effects may occur with sudden cessation of chronic use, though the nature and severity of physical withdrawal symptoms have not been well characterizedcitation needed due to limited research.

Psychosis Risk

As with other stimulants, abuse at high dosages for prolonged periods may result in stimulant psychosis presenting with paranoia, hallucinations, or delusions. Psychosis very rarely arises from occasional or moderate use.

Seizure Risk

Seizure risk from ethylone alone has not been documented in the available literature.

History & Culture

Ethylone is a synthetic cathinone that represents the β-keto analogue of MDEA, a substance colloquially known as "Eve."1 The compound has only a brief history of documented human use, with minimal records of consumption prior to its commercial emergence around

Legality

International

Ethylone is not listed under the 1961 Single Convention on Narcotic Drugs. It is listed in a schedule of the 1971 Convention on Psychotropic Substances. It is not listed under the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.

By Country

Illegal24
United States flagUnited StatesIllegal
Argentina flagArgentinaIllegal
Australia flagAustraliaIllegal
Austria flagAustriaIllegal (analog/blanket ban)
Brazil flagBrazilIllegal
China flagChinaIllegal
Denmark flagDenmarkIllegal
Finland flagFinlandIllegal
France flagFranceIllegal (analog/blanket ban)
Germany flagGermanyIllegal
India flagIndiaIllegal
Indonesia flagIndonesiaIllegal
Italy flagItalyIllegal
Japan flagJapanIllegal
Netherlands flagNetherlandsIllegal
Norway flagNorwayIllegal
Poland flagPolandIllegal
Portugal flagPortugalIllegal
Singapore flagSingaporeIllegal
South Korea flagSouth KoreaIllegal (analog/blanket ban)
Sweden flagSwedenIllegal
Switzerland flagSwitzerlandIllegal (analog/blanket ban)
Ukraine flagUkraineIllegal
United Kingdom flagUnited KingdomIllegal

References

Source Pages

  1. Bluelight: Ethylone / BK-MDEA Discussion Thread
  2. Erowid
  3. Isomer Design (TiHKAL/PiHKAL)
  4. PsychonautWiki
  5. TripSit Factsheets
  6. Wikipedia

Citations

  1. 3,4-Methylenedioxyethcathinone (Ethylone) ["Bath salt," bk-MDEA, MDEC]. (2019). https://www.deadiversion.usdoj.gov/drug_chem_info/ethylone.pdf1
  2. Decreto N° 560/2019. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/nacional/decreto-560-2019-326675/texto1
  3. Decreto N° 560/2019. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/326675_dec560-1_pdf/archivo1
  4. Decreto N° 560/2019. argentina.gob.ar (n.d.). https://www.argentina.gob.ar/normativa/nacional/ley-23737-138/actualizacion1
  5. Criminal Code Regulations 2019. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2019L00561/latest/text1
  6. Criminal Code Regulations 2019. legislation.gov.au (n.d.). https://www.legislation.gov.au/F2025C01260/latest/text1
  7. Criminal Code Regulations 2019. legislation.gov.au (n.d.). https://www.legislation.gov.au/C2004A04868/latest/text1
  8. Neue-Psychoaktive-Substanzen-Verordnung (NPSV), Anlage II Z 4, read with § 4 Neue-Psychoaktive-Substanzen-Gesetz (NPSG). ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/eli/bgbl/ii/2011/468/ANL2/NOR402614411
  9. Neue-Psychoaktive-Substanzen-Verordnung (NPSV), Anlage II Z 4, read with § 4 Neue-Psychoaktive-Substanzen-Gesetz (NPSG). ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf1
  10. Neue-Psychoaktive-Substanzen-Verordnung (NPSV), Anlage II Z 4, read with § 4 Neue-Psychoaktive-Substanzen-Gesetz (NPSG). ris.bka.gv.at (n.d.). https://www.ris.bka.gv.at/eli/bgbl/i/2011/146/P4/NOR401344471

Further Reading

  1. Australian Drug Foundation: Ethylone
  2. Cozzi et al. (1999) - Beta-ketoamphetamine transporter inhibition
  3. Kamata et al. (2006) - Metabolism of bk-MDEA and bk-MBDB

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Ethylone article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.